(1)
A STUDY OF COVID-19 RELATED MUCORMYCOSIS AND ITS SURGICAL MANAGEMENT: OUR EXPERIENCE AT A TERTIARY CARE CENTER. Int. Res. J. Pharm. 2024, 15 (3), 1-8.